Global Partnerships Orexigen has shown a willingness to enter strategic collaborations with large pharma and regional distributors, as evidenced by past deals with Takeda and Consilient Health for Mysimba in the UK and Ireland. This signals a strong appetite for licensing, co-commercialization, or regional partnerships to accelerate market access and reduce standalone risk.

DTC Marketing The Brains Behind Weight Loss campaign demonstrates a readiness to invest in consumer-focused marketing and patient engagement. This creates opportunities to offer integrated multichannel marketing, digital engagement platforms, and patient support/drug adherence programs to broaden reach and optimize demand.

Finance & Monetization A history of bankruptcy-related pressures alongside available funding suggests potential need for strategic financial advisory, IP monetization, or sale of assets. Position services around M&A advisory, licensing strategies, or asset monetization to unlock value from the portfolio.

Regulatory Expertise Orexigen’s experience navigating regulatory hurdles and pursuing corrective trials indicates a strength in regulatory strategy and trial navigation. This presents an opportunity to offer regulatory consulting, trial design optimization, or CRO partnerships to other biotech firms seeking approvals.

Manufacturing Partnerships With a lean workforce focused on pharmaceutical manufacturing, there is potential to pursue contract manufacturing, scale-up support, and supply chain optimization partnerships. Target CDMO-style collaborations to scale commercialization without proportional headcount growth.